Improving Treatment-Related Symptom Management in Adolescents and Young Adults With Cancer
NCT ID: NCT04594096
Last Updated: 2024-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2021-09-30
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Mobile Phone Intervention to Promote Adherence to Survivorship Care Among Adolescent and Young Adult Cancer Survivors
NCT05000359
Peer Mentoring in Promoting Follow-up Care Self-Management in Younger Childhood Cancer Survivors
NCT02699996
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
NCT05443737
Cancer Care Coordination for Chemotherapy Patients
NCT02238951
Developing and Pre-Testing an eHealth Group Intervention for Young Adult Cancer Survivors
NCT05054569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate Intervention Arm
Observation periods will be from 4 days post last administration of chemotherapy until the next chemotherapy administration.
All patients will undergo an initial observation period that will span two chemotherapy cycles and will be receiving clinical care as usual determined by the primary oncology team.
Patients enrolled on the immediate arm will start the intervention (telehealth visits) in Time Period 2 (following chemotherapy cycles 3 and 4). During Time Period 3 (following chemotherapy cycles 5 and 6), this arm will resume clinical care as usual.
Telehealth visits
Receiving telehealth visits with a medical provider (MD or NP) 2-3 days after last chemotherapy administration in the cycle
Standard of Care
Receiving care as usual from the UC Davis Comprehensive Cancer Center
Delayed Intervention Arm
Observation periods will be from 4 days post last administration of chemotherapy until the next chemotherapy administration.
All patients will undergo an initial observation period that will span two chemotherapy cycles and will be receiving clinical care as usual determined by the primary oncology team.
Patients enrolled on the delayed arm will receive clinical care as usual during Time Period 2 (following chemotherapy cycles 3 and 4). During Time Period 3 (following chemotherapy cycles 5 and 6), this arm will start the intervention (telehealth visits).
Telehealth visits
Receiving telehealth visits with a medical provider (MD or NP) 2-3 days after last chemotherapy administration in the cycle
Standard of Care
Receiving care as usual from the UC Davis Comprehensive Cancer Center
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telehealth visits
Receiving telehealth visits with a medical provider (MD or NP) 2-3 days after last chemotherapy administration in the cycle
Standard of Care
Receiving care as usual from the UC Davis Comprehensive Cancer Center
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Access to Epic MyChart (we will facilitate access to MyChart for interested patients who are not yet signed up)
* Access to a smartphone or tablet to access EPIC MyChart telehealth appointments
Exclusion Criteria
* Potentially completing therapy during study period (including follow-up period) or plans to leave UCDCCC during study period
12 Years
29 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Comprehensive Cancer Center
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Naz H, Apesoa-Varano EC, Romero C, Keegan T, Malogolowkin M, Callas C, Gosdin M, Alvarez E. How Do Adolescent and Young Adult Patients with Cancer Manage Their Chemotherapy-Related Symptoms at Home? J Adolesc Young Adult Oncol. 2023 Dec;12(6):923-928. doi: 10.1089/jayao.2022.0153. Epub 2023 Sep 12.
Related Links
Access external resources that provide additional context or updates about the study.
Learn more or sign up for the study here!
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1575166
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.